Ensartinib Treatment Beyond Disease Progression in Stage IV ALK plus Non-Small Cell Lung Cancer Horn, L., Pate, S., Waqar, S., Blumenschein, G., Harrow, K., Holzhausen, A., Liang, C., Dukart, G., Wakelee, H. ELSEVIER SCIENCE INC. 2018: S583

View details for DOI 10.1016/j.jtho.2018.08.860

View details for Web of Science ID 000454014502015